Ignacio Martinez

Ignacio joined Flagship Pioneering in early 2013 and focuses on entrepreneurial activities in life sciences, with a special interest in agriculture, food, nutrition, and human health. Ignacio is currently leading the Pioneering Abundance and Pioneering Health initiatives at Flagship. Ignacio is also a co-founder of multiple companies including Montai Therapeutics, Enai, Terion, Invaio, Indigo Carbon, Inari, Terrana, and Sail Biomedicines. He was also Chairman of the Board of Directors at YourBio Health (acquired by Hims & Hers), and Board Member of Novomer (acquired by Danimer). 

Prior to joining Flagship, Ignacio was founding member and managing director of Syngenta Ventures, the corporate venture capital group of agricultural giant Syngenta International. During his tenure at Syngenta, Ignacio was directly involved in corporate strategy and led venture capital investments in agribusiness, biotechnology, and sustainability companies in Europe, North America, and Latin America.  Prior to Syngenta, Ignacio was the founding CFO of Progenika Group, a company which was acquired by Grifols (NASDAQ: GFRS), the world’s largest supplier of blood plasma products. 

He holds a B.S. in Economics and Business Administration from Deusto University in Spain, and an International M.B.A. from Instituto de Empresa in Spain and WHU Otto Beisheim School of Management in Germany.